DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Robert Kushner - 1 Eli Lilly - 1 Zepbound - 1 Howard Weintraub - 1
Top related locs:
Danish U.S
Top related orgs:
Wegovy - 1 American Heart Association Scientific Sessions - 1 New England - 1 of Medicine - 1 Novo Nordisk - 1 Northwestern University Feinberg School of Medicine - 1 Center for - 1 NYU Langone - 1

Search resuls for: "Howard Weintraub"


2 mentions found


☆ Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
  + stars: | 2023-11-11 | by ( Angelica Peebles | In Angelicapeebles | ) www.cnbc.com   time to read: +2 min
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. Novo Nordisk's Wegovy cut the risk of serious cardiovascular complications in people with obesity and heart disease in a closely watched trial, demonstrating a particularly large effect on heart attacks, a promising new frontier for the drug. The roughly 17,500-person Select study tested Wegovy in people with obesity and heart disease but who did not have diabetes. The new data could also help the Danish pharmaceutical company maintain its lead over Eli Lilly, whose competing weight-loss drug Zepbound was approved in the U.S. earlier this week. Zepbound has been shown to help people lose more weight, but it hasn't yet demonstrated an effect on cardiovascular outcomes.
Persons: Robert Kushner, Eli Lilly, Zepbound, Howard Weintraub Organizations: Wegovy, American Heart Association Scientific Sessions, New England, of Medicine, Novo Nordisk, Northwestern University Feinberg School of Medicine, Center for, NYU Langone Locations: Danish, U.S
☆ 'Good' cholesterol may not protect against heart disease, study finds
  + stars: | 2022-11-21 | by ( Linda Carroll | Linda Carroll Is A Regular Health Contributor To Nbc News | Reuters Health. She Is Coauthor Of | ) www.nbcnews.com   time to read: +6 min
For decades doctors have been telling their patients that high levels of HDL, otherwise known as “good cholesterol,” could protect them from heart disease. But a new study suggests that having a lot of so-called good cholesterol doesn’t mean a lower risk of heart attacks. The new findings surprised the researchers, who originally designed their study to understand how cholesterol levels in Black and white middle-aged adults without heart disease affected their future risks. Previous research on "good" cholesterol and heart disease consisted of mostly white adults. Low HDL levels were associated with an increased risk of coronary heart disease in white participants, but not Black participants.
0 next >>
Total: 2